Other work demonstrates that activation of certain cytokine/chemokine pathways, for example those involving IL‐6 or IL‐8, can promote the recruitment and proliferation of myeloid‐derived suppressor cells (MDSCs), which can contribute to the dysfunction of T cells in cancer immunity.48, 49, 50. This evidence concerns the gene IL6 and cancer.